Search research articles
Contact Us
Filters
Showing results (751-760 of 1,041) with videos related to
Page
of 105
Sort By:
JAMA Oncology
|
June 24, 2021
Prognosis of Patients With Early Breast Cancer Receiving 5 Years vs 2 Years of Adjuvant Bisphosphonate Treatment: A Phase 3 Randomized Clinical Trial
Thomas W P Friedl, Tanja Fehm, Volkmar Müller, et al.
Breast Care (Basel, Switzerland)
|
November 5, 2010
Zurich Consensus: German Expert Opinion on the St. Gallen Votes on 15 March 2009 (11th International Conference at St. Gallen: Primary Therapy of Early Breast Cancer)
Matthias W Beckmann, Jens-Uwe Blohmer, Serban-Dan Costa, et al.
Breast Cancer Research and Treatment
|
May 5, 2018
BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patients
Marius Wunderle, Paul Gass, Lothar Häberle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 6, 2021
The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents
Pauline Dürr, Katja Schlichtig, Carolin Kelz, et al.
Oncotarget
|
November 5, 2017
Clinical validation of genetic variants associated with <i>in vitro</i> chemotherapy-related lymphoblastoid cell toxicity
Peter A Fasching, Lothar Häberle, Brigitte Rack, et al.
Cancers
|
April 12, 2022
MUC1 (CA27.29) before and after Chemotherapy and Prognosis in High-Risk Early Breast Cancer Patients
Hanna Huebner, Lothar Häberle, Volkmar Müller, et al.
Breast Cancer Research and Treatment
|
March 13, 2013
Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis
Christian R Loehberg, Katrin Almstedt, Sebastian M Jud, et al.
Geburtshilfe Und Frauenheilkunde
|
December 23, 2017
Update Breast Cancer 2017 - Implementation of Novel Therapies
Michael P Lux, Wolfgang Janni, Andreas D Hartkopf, et al.
BMC Cancer
|
February 7, 2014
FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients
Peter A Fasching, Sebastian M Jud, Maik Hauschild, et al.
Archives of Gynecology and Obstetrics
|
June 10, 2017
Gynecologic oncologists' attitudes and practices relating to integrative medicine: results of a nationwide AGO survey
Evelyn Klein, Matthias W Beckmann, Werner Bader, et al.
Page
of 105
Search research articles
Search
Showing results (751-760 of 1,041) with videos related to
Sort By:
Page
of 105
JAMA Oncology
|
June 24, 2021
Prognosis of Patients With Early Breast Cancer Receiving 5 Years vs 2 Years of Adjuvant Bisphosphonate Treatment: A Phase 3 Randomized Clinical Trial
Thomas W P Friedl, Tanja Fehm, Volkmar Müller, et al.
Breast Care (Basel, Switzerland)
|
November 5, 2010
Zurich Consensus: German Expert Opinion on the St. Gallen Votes on 15 March 2009 (11th International Conference at St. Gallen: Primary Therapy of Early Breast Cancer)
Matthias W Beckmann, Jens-Uwe Blohmer, Serban-Dan Costa, et al.
Breast Cancer Research and Treatment
|
May 5, 2018
BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patients
Marius Wunderle, Paul Gass, Lothar Häberle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 6, 2021
The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents
Pauline Dürr, Katja Schlichtig, Carolin Kelz, et al.
Oncotarget
|
November 5, 2017
Clinical validation of genetic variants associated with <i>in vitro</i> chemotherapy-related lymphoblastoid cell toxicity
Peter A Fasching, Lothar Häberle, Brigitte Rack, et al.
Cancers
|
April 12, 2022
MUC1 (CA27.29) before and after Chemotherapy and Prognosis in High-Risk Early Breast Cancer Patients
Hanna Huebner, Lothar Häberle, Volkmar Müller, et al.
Breast Cancer Research and Treatment
|
March 13, 2013
Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis
Christian R Loehberg, Katrin Almstedt, Sebastian M Jud, et al.
Geburtshilfe Und Frauenheilkunde
|
December 23, 2017
Update Breast Cancer 2017 - Implementation of Novel Therapies
Michael P Lux, Wolfgang Janni, Andreas D Hartkopf, et al.
BMC Cancer
|
February 7, 2014
FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients
Peter A Fasching, Sebastian M Jud, Maik Hauschild, et al.
Archives of Gynecology and Obstetrics
|
June 10, 2017
Gynecologic oncologists' attitudes and practices relating to integrative medicine: results of a nationwide AGO survey
Evelyn Klein, Matthias W Beckmann, Werner Bader, et al.
Page
of 105